DRDO to launch 2-DG drug for COVID-19 treatment next week The first batch of 10,000 doses of 2DG medicine for treating coronavirus patients will be launched early next week, informed Defence Research and Development Organisation (DRDO) officials BusinessToday.In | May 15, 2021 | Updated 11:53 IST The 2-DG drug helps in faster recovery of the hospitalised COVID-19 patients and also lessens oxygen dependence The first tranche of 10,000 doses of 2-DG medicine for treating coronavirus patients will be launched early next week, informed Defence Research and Development Organisation (DRDO) officials on Friday, May 14. The 2-DG (2-deoxy-D-glucose), an anti-COVID-19 therapeutic application of the drug, has been developed by the Institute of Nuclear Medicine and Allied Sciences (INMAS), a lab of Defence Research and Development Organisation (DRDO), in collaboration with Dr Reddys Laboratories (DRL), Hyderabad.